Back to DSKYFView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
4 competitors in Solid Tumor
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Olmesartan medoxomil tablets high dosePhase 3
Metabolic Syndrome
Platinum ChemotherapyPhase 3
Non-small Cell Lung Cancer
Edoxaban tablets (low dose regimen-30mg)Phase 3
Stroke
Edoxaban tablets (high dose regimen-60mg)Phase 3
Stroke
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tabletsPhase 3
Essential Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
